Barbara Duncan
2011
In 2011, Barbara Duncan earned a total compensation of $483.6K as Chief Financial Officer and Treasurer at Intercept Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $71,760 |
|---|---|
| Option Awards | $93,388 |
| Salary | $312,000 |
| Other | $6,412 |
| Total | $483,560 |
Duncan received $312K in salary, accounting for 65% of the total pay in 2011.
Duncan also received $71.8K in non-equity incentive plan, $93.4K in option awards and $6.4K in other compensation.
Rankings
In 2011, Barbara Duncan's compensation ranked 8,152nd out of 10,747 executives tracked by ExecPay. In other words, Duncan earned more than 24.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,152 out of 10,747 | 24th |
Division Manufacturing | 2,996 out of 3,960 | 24th |
Major group Chemicals And Allied Products | 744 out of 1,038 | 28th |
Industry group Drugs | 534 out of 786 | 32nd |
Industry Pharmaceutical Preparations | 412 out of 571 | 28th |
Source: SEC filing on April 12, 2013.
Duncan's colleagues
We found two more compensation records of executives who worked with Barbara Duncan at Intercept Pharmaceuticals in 2011.